If you were treated for a stomach ulcer anytime between the late 1990s and the early 2020s, you probably took a little blister pack with three medicines in it: an acid reducer, amoxicillin, and clarithromycin. That combination, known as triple therapy, was the standard way to cure Helicobacter pylori for a generation. Today it is a very different story. Clarithromycin resistance has climbed so high that US guidelines now tell doctors not to use classic triple therapy unless a test shows the bacteria are still sensitive to it.
This guide explains clarithromycin for H. pylori from a patient’s point of view: what triple therapy is, why it stopped being the automatic first choice, where clarithromycin still fits (including a newer vonoprazan-based pack), how your 14 days of treatment usually feel, and why the follow-up test afterward matters as much as the pills.
First, What Is H. pylori?
H. pylori is a spiral-shaped bacterium that lives in the mucus lining of the stomach. It survives stomach acid by producing an enzyme called urease, which creates a small cloud of alkaline ammonia around itself. It is extremely common worldwide, often picked up in childhood, and many carriers never have symptoms. In others, it causes long-term stomach inflammation (gastritis), peptic ulcers in the stomach or duodenum, and it is the leading known risk factor for stomach cancer and a type of stomach lymphoma called MALT lymphoma.
Because of those risks, current guidance says that anyone who tests positive should be offered treatment, and anyone treated should be retested to confirm cure.
Then vs Now: How Triple Therapy Lost Its Crown
| Period | What happened |
|---|---|
| 1980s | Australian researchers Barry Marshall and Robin Warren link H. pylori to gastritis and ulcers (they later win the 2005 Nobel Prize). |
| 1990s | Clarithromycin-based triple therapy proves highly effective, with cure rates often above 85 to 90 percent in early studies. It becomes the global standard. |
| 2000s to 2010s | Widespread macrolide use for respiratory infections drives clarithromycin resistance upward. Real-world cure rates for triple therapy drift down, in many places to around 70 to 80 percent or lower. |
| 2017 | The American College of Gastroenterology (ACG) still lists clarithromycin triple therapy as an option, but only where resistance is known to be low and the patient has not taken macrolides before. |
| May 2022 | The FDA approves vonoprazan-based packs, including one that contains clarithromycin (Voquezna Triple Pak) and one without it (Voquezna Dual Pak). |
| September 2024 | A new ACG guideline recommends bismuth quadruple therapy as first choice when susceptibility is unknown and advises against clarithromycin regimens unless susceptibility is proven. |
The 2024 guideline, published in the American Journal of Gastroenterology and indexed on PubMed, was blunt about this shift. One of its authors told Michigan Medicine that, in essentially all circumstances, doctors should not be prescribing PPI triple therapy, even though it still dominated US prescriptions.
What Is Clarithromycin Triple Therapy?
Classic triple therapy combines three drugs, taken twice a day, usually for 14 days:
| Component | Typical adult dose | Job in the regimen |
|---|---|---|
| Proton pump inhibitor (omeprazole, lansoprazole, esomeprazole, pantoprazole, or rabeprazole) | Standard or double dose, twice daily | Lowers acid so the antibiotics work better and the lining can heal |
| Clarithromycin | 500 mg twice daily | Blocks the bacterium’s protein production |
| Amoxicillin | 1,000 mg (1 g) twice daily | Damages the bacterial cell wall |
| Metronidazole (replaces amoxicillin in penicillin allergy) | 500 mg twice daily | Damages bacterial DNA |
The US labeling for clarithromycin lists H. pylori regimens of 10 to 14 days. Modern guidelines favor the full 14 days when any clarithromycin regimen is used, because shorter courses cure fewer people.
Why acid suppression matters so much
Amoxicillin and clarithromycin both lose power in strong acid. H. pylori also divides more actively, and is more vulnerable to antibiotics, when the stomach is less acidic. That is why stronger, more consistent acid suppression improves cure rates, and why newer regimens use vonoprazan, a potassium-competitive acid blocker (PCAB) that suppresses acid more powerfully and more quickly than traditional PPIs.
The Resistance Problem in Plain Terms
Clarithromycin works against H. pylori by binding to its ribosome. A single point mutation in the bacterium’s 23S ribosomal RNA gene stops the drug from binding. Once a strain carries that mutation, clarithromycin does almost nothing against it, and the regimen effectively becomes “PPI plus amoxicillin,” which often fails.
The biggest predictor of a resistant strain is your own past macrolide use. If you have taken clarithromycin, azithromycin (a Z-Pak), or erythromycin for any reason, such as bronchitis, sinusitis, or a skin infection, you are more likely to carry a resistant H. pylori strain. Tell your doctor about every macrolide course you can remember. Our overview of azithromycin (Z-Pak) uses may jog your memory about why you might have taken one.
European consensus guidance has long used 15% local clarithromycin resistance as the cut-off above which empiric triple therapy should be abandoned. Many US and international surveys now report rates around or above that level, though true local data are patchy.
Where Clarithromycin Still Fits in 2026
Clarithromycin is not banned from H. pylori treatment. It has been moved to specific situations:
1. When susceptibility testing shows the strain is sensitive
Molecular tests can now detect the clarithromycin-resistance mutation from a stomach biopsy taken during endoscopy, and increasingly from a stool sample. If your strain is confirmed susceptible, clarithromycin triple therapy can again be an effective, well-tolerated option. Ask whether testing is available before starting treatment, especially if you have taken macrolides before.
2. Vonoprazan triple therapy
The Voquezna Triple Pak contains vonoprazan 20 mg, amoxicillin 1,000 mg, and clarithromycin 500 mg, each taken twice daily for 14 days, as described in the FDA’s Drug Trials Snapshot. In the PHALCON-HP trial of 992 adults, the vonoprazan triple regimen cured about 85% of people whose strains were not resistant, compared with about 79% on lansoprazole triple therapy. The bigger difference was in people with clarithromycin-resistant strains: vonoprazan triple therapy cured roughly two-thirds of them, while the lansoprazole version cured far fewer. The 2024 ACG guideline therefore suggests that, if a clarithromycin regimen is used without susceptibility results, the vonoprazan version is preferable to the PPI version.
3. After other regimens are ruled out
For some people, allergies, side effects, or prior failures narrow the options. A clarithromycin-containing regimen guided by susceptibility testing may be the best remaining choice.
Comparing the Main H. pylori Regimens
| Regimen | Contains clarithromycin? | Pills per day (approx.) | Where it stands in 2024 ACG guidance |
|---|---|---|---|
| Bismuth quadruple (PPI, bismuth, tetracycline, metronidazole) for 14 days | No | Many: given 3 to 4 times daily | Preferred first choice when susceptibility is unknown |
| Rifabutin triple (omeprazole, amoxicillin, rifabutin) for 14 days | No | Several, three times daily | Suitable alternative for people without penicillin allergy |
| Vonoprazan dual (vonoprazan, amoxicillin) for 14 days | No | Moderate | Suitable alternative for people without penicillin allergy |
| Vonoprazan triple (vonoprazan, amoxicillin, clarithromycin) for 14 days | Yes | Moderate, twice daily | Suggested over PPI triple therapy if a clarithromycin regimen is used without testing |
| PPI-clarithromycin triple for 14 days | Yes | Moderate, twice daily | Only when clarithromycin susceptibility is confirmed |
| Concomitant therapy (PPI, clarithromycin, amoxicillin, metronidazole) | Yes | Many, twice daily | Not suggested over bismuth quadruple therapy |
The ACP summary of the guideline is a helpful short read if you want to discuss options with your doctor.
How H. pylori Is Diagnosed Before Treatment
Before any regimen is chosen, the infection has to be confirmed. The main tests are:
| Test | How it works | Good to know |
|---|---|---|
| Urea breath test | Detects active infection through bacterial urease activity | Accurate; acid blockers and recent antibiotics can cause false negatives |
| Stool antigen test | Detects H. pylori proteins in stool | Accurate and non-invasive; some labs can also run molecular resistance testing on stool |
| Endoscopy with biopsy | Tissue examined under the microscope, by rapid urease test, culture, or molecular methods | Allows direct inspection of ulcers and susceptibility testing |
| Blood antibody test | Detects antibodies to H. pylori | Cannot tell current from past infection; not recommended for confirming active infection or cure |
If you are being tested, your clinician may ask you to stop PPIs for about two weeks and avoid antibiotics or bismuth for about four weeks beforehand, when safe. These medicines can suppress the bacteria and hide the infection.
Understanding Cure Rates Without the Jargon
Studies report cure (eradication) rates in two main ways. “Intention-to-treat” counts everyone who started treatment, including those who stopped early because of side effects. “Per-protocol” counts only those who completed the course as directed. Per-protocol rates are always higher. That gap is a reminder that adherence is one of the few factors you control directly: missing doses or stopping early lowers your personal odds of cure, regardless of how good the regimen is on paper.
A rough rule many gastroenterologists use is that a first-line regimen should cure at least 90% of patients who take it correctly. Classic clarithromycin triple therapy no longer reaches that reliably in many places unless the strain is known to be susceptible, which is the core reason for the guideline change.
Your 14-Day Treatment Calendar
Here is what a typical clarithromycin-based course looks like, with practical tips at each stage.
Before day 1
- Give your doctor and pharmacist a full medication list. Clarithromycin interacts with statins, some blood pressure drugs, colchicine, blood thinners, and many others. See our clarithromycin drug interactions guide.
- Mention any penicillin allergy. If it is uncertain, allergy testing may open up amoxicillin-based options; our amoxicillin allergy guide explains how.
- Set two phone alarms about 12 hours apart, for example 8 am and 8 pm.
Days 1 to 3
- Take the acid blocker before meals if your instructions say so (traditional PPIs work best 30 to 60 minutes before eating).
- Expect a bitter or metallic taste to appear early. This is the most common complaint on clarithromycin H. pylori regimens; in trials of clarithromycin with omeprazole, about 15% reported it. Our clarithromycin side effects article includes a taste-coping toolkit.
- Mild nausea and loose stools are common.
Days 4 to 10
- Ulcer pain often improves noticeably as acid falls.
- Do not stop because you feel better. The bacteria are not yet gone.
- If diarrhea becomes frequent, watery, or bloody, or comes with fever, call your doctor.
- Avoid smoking if you can. Smoking is associated with lower cure rates.
Days 11 to 14
- This is where many people slip, with forgotten evening doses. Keep your alarms on.
- Count remaining tablets on day 12 to make sure you will finish exactly on schedule.
After the last dose
- Taste usually returns to normal within days.
- Book your test-of-cure appointment (see below).
- If you were prescribed a PPI for ulcer healing beyond the antibiotic course, follow those instructions, but plan to pause it before the breath test as your doctor directs.
Missed a Dose During Triple Therapy?
Take it as soon as you remember, unless it is nearly time for the next dose. In that case, skip the missed one and continue as normal. Never double up. If you miss several doses, call your prescriber, because the course may need to be extended or changed. Full timing rules are in our clarithromycin dosage guide.
Can You Drink Alcohol During H. pylori Treatment?
It depends on the regimen. Clarithromycin and amoxicillin themselves do not cause a dangerous reaction with alcohol. But if your regimen contains metronidazole (in penicillin-allergy triple therapy, concomitant therapy, or bismuth quadruple therapy), you must avoid alcohol completely during treatment and for at least three days after, because of the risk of flushing, vomiting, and racing heart. Alcohol also irritates the stomach lining you are trying to heal. Details are in clarithromycin and alcohol.
The Test of Cure: Why the Story Does Not End on Day 14
Because no regimen cures everyone, the 2024 ACG guideline calls for universal post-treatment testing. The most common options are:
- Urea breath test: you drink a solution containing labeled urea; if H. pylori is still present, its urease releases labeled carbon dioxide in your breath.
- Stool antigen test: detects H. pylori proteins in a stool sample.
- Endoscopy with biopsy: used if an endoscopy is needed anyway, for example to check that a stomach ulcer has healed.
Timing matters. Testing is usually done at least four weeks after finishing antibiotics. PPIs and vonoprazan can suppress the bacteria and cause a false negative, so they are typically stopped about two weeks before the test, if it is safe to do so. Bismuth also needs a gap. Follow your clinic’s instructions exactly.
If Treatment Fails
A positive test after treatment is frustrating but common. The general principles are:
- Do not repeat the same regimen.
- Avoid clarithromycin in the second round unless testing proves susceptibility. If you failed clarithromycin triple therapy, the strain is probably resistant now.
- Optimized bismuth quadruple therapy is usually suggested if you have not had it; rifabutin triple therapy is an option if you have.
- Susceptibility testing becomes more valuable with each failure.
Cost, Coverage, and Access
Price can shape which regimen you actually receive. Generic PPIs, amoxicillin, and clarithromycin are widely available and usually inexpensive. Branded co-packaged regimens, including vonoprazan packs and some bismuth quadruple capsules, can cost substantially more and may need insurance prior authorization. If cost is a barrier, ask your prescriber whether an equally effective generic-based regimen is appropriate, and ask your pharmacist about manufacturer savings programs. Do not ration doses to stretch a supply; an incomplete course is the most expensive outcome if it fails.
Life After a Successful Cure
- Ulcer healing: curing H. pylori dramatically lowers the chance of ulcers returning. Some people continue an acid reducer for a while to complete healing.
- Reinfection: uncommon in adults in high-income countries, but more frequent where H. pylori remains widespread.
- Symptoms: indigestion caused by the infection often improves, though not every case of dyspepsia is due to H. pylori.
- Cancer risk: eradication reduces, but does not fully eliminate, the risk of stomach cancer, particularly if precancerous changes were already present. Follow any surveillance plan your doctor recommends.
- Pain relievers: if you need anti-inflammatory painkillers long term, ask whether ongoing stomach protection is needed.
Who Should Get Tested for H. pylori?
Testing is commonly recommended for people with:
- A current or past peptic ulcer.
- Persistent indigestion (dyspepsia) without alarm symptoms.
- Long-term aspirin or anti-inflammatory use with ulcer risk.
- Unexplained iron deficiency anemia. If that is you, our guide on how to increase hemoglobin covers recovery steps.
- Low platelet counts of unknown cause (immune thrombocytopenia).
- A family history of stomach cancer, or family members living in the same household who were diagnosed with H. pylori.
- MALT lymphoma, or early stomach cancer that has been removed.
Alarm symptoms, such as vomiting blood, black tarry stools, trouble swallowing, unintended weight loss, or a lump in the abdomen, need prompt medical attention rather than a simple test-and-treat approach.
Special Situations
Penicillin allergy
If you have a confirmed penicillin allergy, amoxicillin-based regimens, including vonoprazan dual therapy and rifabutin triple therapy, are not options. Bismuth quadruple therapy does not contain a penicillin and is usually preferred. A clarithromycin-metronidazole combination is possible only when susceptibility supports it. Because most penicillin allergy labels are inaccurate, formal allergy testing can widen your choices.
Pregnancy and breastfeeding
H. pylori treatment is generally postponed until after pregnancy unless there is a pressing reason, such as a bleeding ulcer. Clarithromycin labeling advises against use in pregnancy unless no alternative exists, and tetracycline in bismuth regimens is also avoided in pregnancy. Discuss timing with your obstetric and gastroenterology teams.
Older adults
Older patients are more likely to take medicines that interact with clarithromycin, such as statins, calcium channel blockers, and anticoagulants. Bismuth quadruple therapy avoids these CYP3A4 interactions, though its pill burden can be a challenge. A pill organizer or blister pack prepared by the pharmacy can help.
People with heart disease
The FDA advises caution with clarithromycin in people with heart disease, based on long-term follow-up of a trial in coronary patients. For H. pylori, where clarithromycin-free regimens are now preferred anyway, this is another reason to consider alternatives. See clarithromycin heart risks.
Children
Children with H. pylori are managed by pediatric gastroenterologists, often with susceptibility-guided treatment, because of high clarithromycin resistance in many populations and differences in which drugs are suitable for children.
Side Effects Specific to Clarithromycin Regimens
| Symptom | Likely cause | What to do |
|---|---|---|
| Metallic or bitter taste | Clarithromycin (and metronidazole if included) | Mints, cold water, brush often; harmless |
| Diarrhea | Amoxicillin and clarithromycin | Fluids; call if severe, bloody, or with fever |
| Nausea | Clarithromycin, metronidazole | Take antibiotics with food |
| Rash | Most often amoxicillin | Call your doctor; seek urgent care if blistering or swelling |
| Headache | PPI or antibiotics | Simple pain relief; report if severe |
| Black tongue or stools | Bismuth (quadruple therapy only) | Expected and harmless with bismuth; black stool without bismuth needs urgent review |
Frequently Asked Questions
Is clarithromycin still used for H. pylori?
Yes, but selectively. US guidance limits classic PPI-clarithromycin triple therapy to strains proven susceptible. Clarithromycin also appears in the vonoprazan triple pack, which performs better than older triple therapy, especially against resistant strains.
How effective is clarithromycin triple therapy today?
It depends heavily on local resistance. Against susceptible strains it works well. Against resistant strains, cure rates drop sharply. That uncertainty is why testing or alternative regimens are now preferred.
Why do I need two antibiotics plus an acid reducer?
H. pylori becomes resistant quickly when exposed to a single antibiotic. Combining two antibiotics with strong acid suppression cures more people and reduces the chance of resistance developing during treatment.
Can I take a probiotic during treatment?
The 2024 ACG guideline found insufficient evidence that probiotics improve cure rates or side effects of H. pylori therapy. They are not harmful for most people, but they are not a substitute for completing your regimen.
Do my family members need treatment too?
Household members are not automatically treated, but testing is reasonable if they have symptoms, risk factors, or a family history of stomach cancer. Ask your doctor.
The Bottom Line
Clarithromycin triple therapy cured millions of ulcers, but resistance has turned it from a default into a targeted tool. In 2026, the smart questions are: Has my strain been tested? Have I taken macrolides before? Would bismuth quadruple therapy or a vonoprazan regimen suit me better? Whatever you take, finish all 14 days and do the follow-up test, because a negative test-of-cure is the only proof the infection is really gone. For background on how clarithromycin works and its other uses, see our clarithromycin uses guide.
This article is for educational purposes and is not a substitute for advice from your gastroenterologist, primary care doctor, or pharmacist.
